サインイン

Eliza Guti

Department of Medical Chemistry,
Faculty of Medicine,
Doctoral School of Molecular Medicine,
Department of Medical Chemistry, Faculty of Medicine

BIOGRAPHY

Eliza Guti has not added Biography.

If you are Eliza Guti and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.

Cancer immunology, immunotherapy : CII Sep, 2022 | Pubmed ID: 35066605

INSTITUTIONS

University of Debrecen

JOVE ARTICLES

Eliza Guti^*,1,2,

Ákos Máté Bede^*,1,3,

Csongor Váróczy^*,1,3,

Csaba Hegedűs¹,

Máté Á. Demény^1,4,

László Virág^1,4

¹Department of Medical Chemistry, Faculty of Medicine, University of Debrecen,

²Doctoral School of Molecular Medicine, University of Debrecen,

³National Academy of Scientist Education, University of Debrecen,

⁴, ELKH-DE Cell Biology and Signaling Research Group

Cancer Research

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

教育

著者

図書館員

JoVEについて